Biotechnology entrepreneur and executive, Dr. Shawn Iadonato, has a distinguished career as a founder and C-level executive (CEO, COO, CSO) for both public and private biotech companies. He has extensive experience in founding, funding, and building innovative businesses with groundbreaking technologies.
CounterX Therapeutics is at the forefront of the battle against the opioid epidemic, exploiting cutting-edge biotechnology to develop life-saving therapeutics and vaccines. We combine scientific expertise with an experienced leadership team and a deep commitment to social impact. Our groundbreaking antibody therapies are designed to blunt the effects of opioids, reduce the risk of overdose, and provide a path to recovery. Additionally, our pioneering vaccine technology aims to prevent addiction relapse by blocking the euphoric effects of opioids and empowering individuals to maintain a long-term recovery.
